Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice

Recent clinical trials have demonstrated that combination therapy with renin-angiotensin system inhibitors plus calcium channel blockers (CCBs) elicits beneficial effects on cardiovascular and renal events in hypertensive patients with high cardiovascular risks. In the present study, we hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafiq, Kazi, Sherajee, Shamshad J., Hitomi, Hirofumi, Nakano, Daisuke, Kobori, Hiroyuki, Ohmori, Koji, Mori, Hirohito, Kobara, Hideki, Masaki, Tsutomu, Kohno, Masakazu, Nishiyama, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858271/
https://www.ncbi.nlm.nih.gov/pubmed/24339994
http://dx.doi.org/10.1371/journal.pone.0082082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858271/
https://www.ncbi.nlm.nih.gov/pubmed/24339994
http://dx.doi.org/10.1371/journal.pone.0082082

Ejemplares similares